Organization Profile

You just read:

Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine

News provided by

Polpharma Biologics S.A

Sep 03, 2019, 01:15 ET